Open AccessJournal Article
Establishment and characterization of a human prostatic carcinoma cell line (PC-3).
TLDR
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported, which should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agents.Abstract:
The establishment, characterization, and tumorigenicity of a new epithelial cell line (PC-3) from a human prostatic adenocarcinoma metastatic to bone is reported The cultured cells show anchorage-independent growth in both monolayers and in soft agar suspension and produce subcutaneous tumors in nude mice Culture of the transplanted tumor yielded a human cell line with characteristics identical to those used initially to produce the tumor PC-3 has a greatly reduced dependence upon serum for growth when compared to normal prostatic epithelial cells and does not respond to androgens, glucocorticoids, or epidermal or fibroblast gowth factors Karyotypic analysis by quinacrine banding revealed the cells to be completely aneuploid with a modal chromosome number in the hypotriploid range At least 10 distinctive marker chromosomes were identified The overall karyotype as well as the marker chromosomes are distinct from those of the HeLa cell Electron microscopic studies revealed many features common to neoplastic cells of epithelial origin including numerous microvilli, junctional complexes, abnormal nuclei and nucleoli, abnormal mitochondria, annulate lamellae, and lipoidal bodies Overall, the functional and morphologic characteristics of PC-3 are those of a poorly-differentiated adenocarcinoma These cells should be useful in investigating the biochemical changes in advanced prostatic cancer cells and in assessing their response to chemotherapeutic agentsread more
Citations
More filters
Journal ArticleDOI
Integrated Multimodal Imaging of Dynamic Bone-Tumor Alterations Associated with Metastatic Prostate Cancer
Jean-Christophe Brisset,Benjamin A. Hoff,Thomas L. Chenevert,Jon A. Jacobson,Jennifer L. Boes,Stefanie Galbán,Alnawaz Rehemtulla,Timothy D. Johnson,Kenneth J. Pienta,Craig J. Galbán,Charles R. Meyer,Timothy Schakel,Klaas Nicolay,Ajjai Alva,Maha Hussain,Brian D. Ross +15 more
TL;DR: Voxel-based analysis of diffusion-weighted MRI and CT scans is used to simultaneously evaluate temporal changes in normal bone homeostasis along with prostate bone metatastsis to deliver an improved understanding of the spatiotemporal local microenvironment.
Journal ArticleDOI
Design, syntheses, and characterization of pharmacophore based chemokine receptor CCR5 antagonists as anti prostate cancer agents.
Christopher K. Arnatt,Saheem A. Zaidi,Zhu Zhang,Guo Li,Amanda C. Richardson,Joy L. Ware,Yan Zhang +6 more
TL;DR: A unique structural skeleton for CCR5 antagonist was constructed and functionalized, resulting in a new series of small molecules to be synthesized and characterized, which provided a potential lead compound for future C CR5 antagonist development focusing on prostate cancer therapy.
Journal ArticleDOI
Radiosensitivity of human prostate cancer and malignant melanoma cell lines.
M.R. Wollin,Thomas J. Fitzgerald,M.A. Santucci,Mani Menon,C. Longcope,Frank R. Reale,J. Carlson,Mary Ann Sakakeeny,Joel S. Greenberger +8 more
TL;DR: The data support the concept that all malignant melanoma cell lines do not show a broad-shouldered cell survival curve in vitro and intrinsic cellular radioresistance, and the in vitro radiosensitivity of androgen receptor positive prostate cancer cell lines is not necessarily altered by the presence of androgens before or after irradiation.
Journal ArticleDOI
Apoptosis as Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer
Francesca Corsi,Francesco Capradossi,Andrea Pelliccia,Stefania Briganti,E. Bruni,Enrico Traversa,Francesco Torino,Albrecht Reichle,Lina Ghibelli +8 more
TL;DR: It is shown that epigenetic reprogramming assists Phoenix Rising to promote post-therapy cancer repopulation and acquired cell-resistance (CRAC) in prostate cancer.
Journal ArticleDOI
Post-Transcriptional Regulation of PARP7 Protein Stability Is Controlled by Androgen Signaling.
Teddy Kamata,Chun-Song Yang,Tiffany A. Melhuish,Henry F. Frierson,David Wotton,Bryce M. Paschal +5 more
TL;DR: The PARP family member, PARP7, is a mono-ADP-ribosyltransferase that has been suggested to play a tumor suppressive role in breast, ovarian, and colorectal cancer.